Historically, Handok has been the entry point of multinational companies to Korea. Now Handok is reinventing itself as a total healthcare company with global ambitions. Its chairman and CEO, Young-jin Kim, explains how he has continued his father’s legacy while also driving the transition to new product development by following an open innovation model and diversifying the company’s portfolio into OTC drugs, medical devices and health functional foods through partnerships and acquisitions.
We have always been regarded as the benchmark for manufacturing quality among other Korean companies
